Jean-Luc Houeto
Overview
Explore the profile of Jean-Luc Houeto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2313
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Weiss D, Landoulsi Z, May P, Sharma M, Schupbach M, You H, et al.
Parkinsonism Relat Disord
. 2022 Sep;
103:169-174.
PMID: 36117018
Purpose: The decision for subthalamic deep brain stimulation (STN-DBS) in Parkinson's disease (PD) relies on clinical predictors. Whether genetic variables could predict favourable or unfavourable decisions is under investigation. Objective:...
12.
Meira B, Lhommee E, Schmitt E, Klinger H, Bichon A, Pelissier P, et al.
J Parkinsons Dis
. 2022 May;
12(5):1665-1676.
PMID: 35527563
Background: Previous studies described a parkinsonian personality characterized as rigid, introverted, and cautious; however, little is known about personality traits in de novo Parkinson's disease (PD) patients and their relationships...
13.
Todt I, Al-Fatly B, Granert O, Kuhn A, Krack P, Rau J, et al.
Mov Disord
. 2022 Feb;
37(2):291-301.
PMID: 35112384
Background: Subthalamic nucleus deep brain stimulation (STN-DBS) effectively treats motor symptoms and quality of life (QoL) of advanced and fluctuating early Parkinson's disease. Little is known about the relation between...
14.
Rascol O, Cochen De Cock V, Pavy-Le Traon A, Foubert-Samier A, Thalamas C, Sommet A, et al.
Mov Disord
. 2021 Apr;
36(7):1704-1711.
PMID: 33792958
Background: There are no effective treatments for multiple system atrophy (MSA). Objective: The objective of this study was to assess the efficacy and safety of the serotonin reuptake inhibitor fluoxetine...
15.
Fouyssac M, Puaud M, Ducret E, Marti-Prats L, Vanhille N, Ansquer S, et al.
Eur J Neurosci
. 2020 Dec;
53(6):1794-1808.
PMID: 33332672
The transition from controlled drug use to drug addiction depends on an interaction between a vulnerable individual, their environment and a drug. Here we tested the hypothesis that conditions under...
16.
Maltete D, Wallon D, Bourilhon J, Lefaucheur R, Danaila T, Thobois S, et al.
Neurology
. 2020 Nov;
96(5):e684-e697.
PMID: 33199437
Objectives: Nucleus basalis of Meynert deep brain stimulation (NBM-DBS) has been proposed for patients with dementia. Here, we aim to assess the safety and effects of NBM-DBS in patients with...
17.
Santin M, Voulleminot P, Vrillon A, Hainque E, Bereau M, Lagha-Boukbiza O, et al.
Mov Disord
. 2020 Oct;
36(3):750-757.
PMID: 33022101
Background: Impact of subthalamic deep brain stimulation (DBS) on impulse control disorders (ICD) in Parkinson's disease (PD) remains controversial. Objectives: The objectives of this study were to analyze the natural...
18.
Tarrano C, Lamy J, Delorme C, McGovern E, Atkinson-Clement C, Brochard V, et al.
Mov Disord
. 2020 Sep;
35(12):2356-2357.
PMID: 32960985
No abstract available.
19.
Martinez-Martin P, Deuschl G, Tonder L, Schnitzler A, Houeto J, Timmermann L, et al.
PLoS One
. 2020 Aug;
15(8):e0237498.
PMID: 32822437
The EARLYSTIM Study compared deep brain stimulation (DBS) with best medical treatment (BMT) over 2-years, showing a between-group difference of 8.0 from baseline in favor of DBS in health-related quality...
20.
Atkinson-Clement C, Tarrano C, Porte C, Wattiez N, Delorme C, McGovern E, et al.
Sci Rep
. 2020 Aug;
10(1):13933.
PMID: 32811896
Myoclonus-dystonia (MD) is a syndrome characterized by myoclonus of subcortical origin and dystonia, frequently associated with psychiatric comorbidities. The motor and psychiatric phenotypes of this syndrome likely result from cortico-striato-thamalo-cerebellar-cortical...